GSK’s attempt to relaunch Blenrep was blocked by FDA advisers due to poor clinical benefit, safety concerns, and eye-related ...

Blaxel raises $7.3M seed funding to build specialized cloud infrastructure for AI agents, challenging AWS with purpose-built platform for autonomous AI systems.